F. A. Holmes

Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.

F. A. Holmes · PubMed · 1996 · 48 citations

Medicine, Oncology, Pharmacology +14

Correlation of molecular effects and pathologic complete response to preoperative lapatinib and trastuzumab, separately and combined prior to neoadjuvant breast cancer chemotherapy.

F. A. Holmes, Yasir M. Nagarwala, Virginia Espina et al. · Journal of Clinical Oncology · 2011 · 48 citations

Medicine, Oncology, Pharmacology +17

Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.

Giuseppe Fraschini, A. A. Ciociola, Leticia Esparza et al. · Journal of Clinical Oncology · 1991 · 42 citations

Medicine, Pharmacology, Pharmacotherapy +17

Abstract GS4-07: Results from a randomized placebo-controlled phase 2 trial evaluating exemestane ± enzalutamide in patients with hormone receptor–positive breast cancer

Ian E. Krop, V Abramson, Marco Colleoni et al. · Cancer Research · 2018 · 33 citations

Medicine, Oncology, Pharmacology +16

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial

Suzette Delaloge, David Cella, Ying-Xuan Ye et al. · Annals of Oncology · 2019 · 25 citations · Full text

Medicine, Oncology, Pharmacology +16